Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study

Greiner, M. G., Shulman, M., Opara, O., Potter, K., Voronca, D. C., Tafessu, H. M., Hefner, K., Hamilton, A., Scheele, C., Ho, R., Dresser, L., Jelstrom, E., Fishman, M., Ghitza, U. E., Rotrosen, J., Nunes, E. V., & Bisaga, A. (2023). Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study. Contemporary Clinical Trials, 128, 107148. https://doi.org/10.1016/j.cct.2023.107148
Authors:
Miranda G Greiner
Matisyahu Shulman
Onumara Opara
Kenzie Potter
Delia C Voronca
Hiwot M Tafessu
Kathryn Hefner
Amy Hamilton
Christina Scheele
Rachel Ho
Lauren Dresser
Eve Jelstrom
Marc Fishman
Udi E Ghitza
John Rotrosen
Edward V Nunes
Adam Bisaga
Affiliated Authors:
Miranda G Greiner
Matisyahu Shulman
Onumara Opara
Kenzie Potter
Edward V Nunes
Adam Bisaga
Subjects:
Author Keywords:
clinical trials network
extended-release injectable naltrexone
hybrid effectiveness-implementation trial
opioid use disorder
rapid induction procedure
stepped wedge design
Publication Type:
Article
Unique ID:
10.1016/j.cct.2023.107148
PMID:
Publication Date:
Data Source:
PubMed

Record Created: